Literature DB >> 27795379

Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Abdullah M S Al-Hatmi1,2,3, Anne-Cécile Normand4, Stephane Ranque4, Renaud Piarroux4, G Sybren de Hoog5,2, Joseph Meletiadis6,7, Jacques F Meis8,9.   

Abstract

We compared EUCAST and CLSI methods versus Etest for antifungal susceptibility testing of 20 clinically relevant Fusarium species against amphotericin B, posaconazole, and voriconazole. The median Etest amphotericin B and posaconazole MICs were 1 dilution higher than the median EUCAST and the CLSI MICs. The essential agreement (within ±1/±2 dilutions) was 60/90%, 80/95%, and 70/85% between the Etest and EUCAST methods and 80/95%, 75/95%, and 45/100% between the Etest and CLSI methods for amphotericin B, voriconazole, and posaconazole, respectively. The categorical agreement was >85%. Etest can be used for antifungal susceptibility testing of Fusarium species.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  CLSI; EUCAST; Etest; Fusarium; RPB2; TEF1; amphotericin B; antifungal susceptibility; comparison; posaconazole; voriconazole

Mesh：

Substances：

Year:  2016        PMID： 27795379      PMCID： PMC5192122          DOI： 10.1128/AAC.01671-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).

Authors:  Elmer Y Tu; David L McCartney; Richard F Beatty; Kathryn L Springer; Jaime Levy; Deepak Edward
Journal:  Am J Ophthalmol       Date:  2006-12-08       Impact factor: 5.258

2.  Susceptibility of 100 filamentous fungi: comparison of two diffusion methods, Neo-Sensitabs and E-test, for amphotericin B, caspofungin, itraconazole, voriconazole and posaconazole.

Authors:  Ioana A Colosi; Odile Faure; Bérangére Dessaigne; Cécile Bourdon; Bernadette Lebeau; Horaţiu A Colosi; Hervé Pelloux
Journal:  Med Mycol       Date:  2011-10-10       Impact factor: 4.076

3.  Fusarium peritonitis successfully managed with posaconazole and catheter removal.

Authors:  Punit J Shah; Scott Bergman; Srivalli Vegi; Vidya Sundareshan
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

4.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.

Authors:  Abdullah M S Al-Hatmi; Anne D van Diepeningen; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

6.  Rapid identification of clinical members of Fusarium fujikuroi complex using MALDI-TOF MS.

Authors:  Abdullah M S Al-Hatmi; Anne-Cécile Normand; Anne D van Diepeningen; Marijke Hendrickx; G Sybren de Hoog; Renaud Piarroux
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

7.  International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.

Authors:  A Espinel-Ingroff; A L Colombo; S Cordoba; P J Dufresne; J Fuller; M Ghannoum; G M Gonzalez; J Guarro; S E Kidd; J F Meis; T M S C Melhem; T Pelaez; M A Pfaller; M W Szeszs; J P Takahaschi; A M Tortorano; N P Wiederhold; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

8.  In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.

Authors:  Abdullah M S Al-Hatmi; Joseph Meletiadis; Ilse Curfs-Breuker; Alexandro Bonifaz; Jacques F Meis; G Sybren De Hoog
Journal:  J Antimicrob Chemother       Date:  2015-12-24       Impact factor: 5.790

9.  Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Emilia Mellado; Juan Luís Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2008-02-08       Impact factor: 5.790

10.  In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.

Authors:  Saad J Taj-Aldeen; Husam Salah; Abdullah M S Al-Hatmi; Manal Hamed; Bart Theelen; Anne D van Diepeningen; Teun Boekhout; Cornelia Lass-Flörl
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-12       Impact factor: 2.803
View more
  14 in total

1.  In Vitro Susceptibility of Fusarium to Isavuconazole.

Authors:  A Broutin; J Bigot; Y Senghor; A Moreno-Sabater; J Guitard; C Hennequin
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Validation of a New Web Application for Identification of Fungi by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  A C Normand; P Becker; F Gabriel; C Cassagne; I Accoceberry; M Gari-Toussaint; L Hasseine; D De Geyter; D Pierard; I Surmont; F Djenad; J L Donnadieu; M Piarroux; S Ranque; M Hendrickx; R Piarroux
Journal:  J Clin Microbiol       Date:  2017-06-21       Impact factor: 5.948

3.  Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.

Authors:  Mahdi Abastabar; Abdullah M S Al-Hatmi; Mohammad Vafaei Moghaddam; G Sybren de Hoog; Iman Haghani; Seyed Reza Aghili; Tahereh Shokohi; Mohammad Taghi Hedayati; Roshanak Daie Ghazvini; Reza Kachuei; Ali Rezaei-Matehkolaei; Koichi Makimura; Jacques F Meis; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations.

Authors:  Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 5.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

6.  Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods.

Authors:  Marion Blaize; Anne-Cecile Normand; Sebastien Imbert; Abdullah M S Al-Hatmi; Erja Chryssanthou; Sophie Cassaing; Christine Schuttler; Lilia Hasseine; Caroline Mahinc; Damien Costa; Christine Bonnal; Stéphane Ranque; Marc Sautour; Elisa Rubio; Laurence Delhaes; Arnaud Riat; Boualem Sendid; Lise Kristensen; Marcel Brandenberger; Dirk Stubbe; Sophie Brun; Renaud Piarroux; Arnaud Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2021-09-20       Impact factor: 5.191

Review 7.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

8.  In vitro susceptibility testing for black grain eumycetoma causative agents.

Authors:  Wendy W J van de Sande
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-04-14       Impact factor: 2.184

Review 9.  Antifungal Susceptibility Testing of Fusarium: A Practical Approach.

Authors:  Abdullah M S Al-Hatmi; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis; Paul E Verweij
Journal:  J Fungi (Basel)       Date:  2017-04-26

10.  A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica.

Authors:  Jasper Elvin James; Erwin Lamping; Jacinta Santhanam; Trudy Jane Milne; Mohd Fuat Abd Razak; Latiffah Zakaria; Richard David Cannon
Journal:  Front Microbiol       Date:  2020-03-31       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.